Copyright Trademark

Copyright Board to be Taken Over by IPAB Under the Finance Bill, 2017 Passed by the Lok Sabha

by
2 Comments

In a surprising development, the Copyright Board is set to be merged with the Intellectual Property Appellate Board (IPAB) under the Finance Bill, 2017 that was passed in the Lok Sabha yesterday. This merger comes along with merger of seven other tribunals (including the Competition Law Appellate Tribunal and the Cyber Appellate Tribunal) with other existing tribunals, all of which were proposed by the amendments to the Bill moved by the Finance Minister Arun Jaitley on Tuesday. The Bill seeks…


Read More »
Others Sponsored

Launch of EIPIN Innovation Society Project: 15 Fully-Funded PhD Positions

by
Leave a Comment

We are pleased to remind our readers that the European IP Institutes Network (EIPIN) will soon be launching the EIPIN Innovation Society project that sets up a European Joint Doctorate programme. EIPIN is recruiting 15 PhD candidates for this programme, who will be conferred a joint or double doctoral degree from two of the five participating universities at the end of the programme. The deadline for applications is March 29, 2017, 23.59 CET. The details of the project are outlined in…


Read More »
Publication

Socio-Legal Review Launches Its Online Companion/Blog, the Socio-Legal Review Forum

by
Leave a Comment

We are pleased to inform our readers that the Editorial Board of the Socio-Legal Review has launched its online companion/blog, the Socio-Legal Review Forum. The Board’s announcement reads as follows: Since its inception in 2005, SLR has strived to further the discourse on the intersection of law and society. Over the past decade, it has provided both students and scholars a platform to engage with socio-legal matters relevant in the South Asian context. Since it became a biannual publication in 2012, it has produced a…


Read More »
Patent

SpicyIP Fellowship 2017-18: Del HC Upholds Interim Injunction Against Sale of Cipla’s Copy of Novartis’ Respiratory Drug ‘Onbrez’

by
1 Comment

We are pleased to bring to you a guest post by our Fellowship applicant, Shweta Rankhambe. This is her first submission for the Fellowship. In this post she discusses the Delhi High Court’s recent judgment upholding an injunction order passed by the Single Judge in 2015 which temporarily restrained Cipla from manufacturing and selling a generic version of Novartis’ patented respiratory drug ‘INDACATEROL’ (sold as ‘Onbrez’). The judgment is significant in that it acknowledges ‘public interest’ as a separate factor…


Read More »
Others Sponsored

SpicyIP Jobs: Research Fellows (Law) at CIIPC, NLU Delhi; Applications Close on March 15

by
Leave a Comment

We’re happy to remind our readers that the National Law University, Delhi (‘University’) is seeking to engage, on a contractual basis, three full-time RESEARCH FELLOWS (LAW) for the CENTRE FOR INNOVATION, INTELLECTUAL PROPERTY AND COMPETITION (CIIPC), at its campus in Dwarka, New Delhi. The deadline for sending applications is tomorrow, March 15, 2017. About the Centre: CIIPC was established in the year 2015 with the objective of contributing to academic and policy oriented dialogues in the areas of innovation, IP…


Read More »
Copyright

Publishers Release Public Statement on Withdrawal of DU Photocopy Case

by
Leave a Comment

As all of you already know, last week, the publishers (OUP, CUP and T&F) surprisingly withdrew the copyright infringement suit filed against DU and Rameshwari photocopy shop in 2012 for creation and distribution of course packs containing excerpts from their copyrighted books. While the reason for the withdrawal is not clear, it is heartening to note that the publishers, in a public statement released on March 9, expressed their intention to work “even more closely with academic institutions, teachers and…


Read More »
Others

SpicyIP Jobs: Research Fellows at ARCIALA, SMU (School of Law)

by
Leave a Comment

SpicyIP is happy to announce that the School of Law at the Singapore Management University (SMU) has an opening for up to two Research Fellow/Research Associate positions for its Applied Research Centre for Intellectual Assets and the Law in Asia (ARCIALA). The details are as follows: Job Qualifications Advanced Degree in Law (LLM or Master of Law) from a reputable university required, preferably a PhD candidate with a topic related to intellectual property. Fluency in English required. Existing publication record in…


Read More »
Event

SpicyIP Events: International Conference on the TRIPS CBD Linkage: Issues and Way Forward

by
Leave a Comment

We are pleased to announce that the Centre for WTO Studies, Indian Institute of Foreign Trade, New Delhi is organising an International Conference on the TRIPS CBD Linkage: Issues and Way Forward. The Conference will be held on March 15-17, 2017 at the Conference Hall, IInd Floor, Indian Institute of Foreign Trade, New Delhi. The draft agenda for the Conference can be viewed here.


Read More »
Geographical Indication Innovation Others Patent

SpicyIP Fellowship 2017-18: Where are the Women in IPR? Still a Long Way to Go

by
Leave a Comment

  On the occasion of International Women’s Day, we are pleased to bring to you a guest post on gender and IP by our Fellowship applicant, Afreen Hashmi. This is her first submission for the Fellowship. Our earlier posts on this theme can be viewed here and here. Where are the Women in IPR? Still a Long Way to Go Afreen Hashmi James Watt invented steam engines, Alexander Graham Bell invented the telephone, the Wright Brothers invented aeroplane; whereas Thomas Edison…


Read More »
Patent

Del HC Allows Natco to Export Bayer’s Nexavar under the Bolar Exemption

by
1 Comment

In a significant development today, Justice Endlaw of the Delhi High Court held that ‘export’ of a patented invention for experimental purposes is also covered under Section 107A of the Patents Act, 1970 (India’s Bolar exemption) and thus does not amount to patent infringement. It accordingly allowed Natco to export Bayer’s patented drug ‘Sorafenib Tosylate’ (for which it was granted a compulsory license in 2012) to China for the purpose of conducting development/ clinical studies and trials. It rejected Bayer’s…


Read More »
  1. Pages:
  3. 1
  4. ...
  5. 21
  6. 22
  7. 23
  8. 24
  9. 25
  10. 26
  11. 27
  12. 28
  13. 29
  14. ...
  15. 34